Company

Actithera

Biotechnology Research Oslo, No 6 employees

Employees: 6
Contacts: 1
Emails: 1
Phones: 1

actithera.com LinkedIn Crunchbase

Actithera Overview

Headquarters: Oslo, No
Website: actithera.com
Industry: Biotechnology Research
Employees: 6
Funding: 75.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Actithera

Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.

Actithera Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

Actithera Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nadiya Ishnazarova	Principal at M Ventures, Biotechnology		View
Hakan Goker	Managing Director at M Ventures - Head		View
Paolo Aurilio		United States	Email Phone